Clinical Trials Directory

Trials / Completed

CompletedNCT03049059

A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Mae Fah Luang University Hospital · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A Comparative study for Efficacy and Safety Between 4% hydroquinone cream with or without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma

Detailed description

Primary Objective: * To compare clinical efficacy by Modified MASI score between Fractional Picosecond 1,064 nm laser and daily application of 4% hydroquinone with 4% hydroquinone alone Secondary objectives * To compare the clinical endpoints of Mexameter Melanin Index, brownish spot and Ultraviolet spots by VISIATM complexion analysis, The Antera 3D® imaging technology for pigmentation, quality of life by Dermatology Life Quality Index and patient's satisfaction between Fractional Picosecond 1,064 nm laser and 4% hydroquinone with 4% hydroquinone alone

Conditions

Interventions

TypeNameDescription
DEVICEFractional Picosecond 1,064 nm laserFractional Picosecond 1,064 nm laser and daily application with 4% hydroquinone cream
DRUG4% hydroquinone cream

Timeline

Start date
2016-06-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2017-02-09
Last updated
2017-02-09

Source: ClinicalTrials.gov record NCT03049059. Inclusion in this directory is not an endorsement.